ATE533764T1 - Verfahren zur herstellung von solifenacin - Google Patents

Verfahren zur herstellung von solifenacin

Info

Publication number
ATE533764T1
ATE533764T1 AT07855994T AT07855994T ATE533764T1 AT E533764 T1 ATE533764 T1 AT E533764T1 AT 07855994 T AT07855994 T AT 07855994T AT 07855994 T AT07855994 T AT 07855994T AT E533764 T1 ATE533764 T1 AT E533764T1
Authority
AT
Austria
Prior art keywords
solifenacin
pharmaceutically acceptable
base
hydrogen tartrate
transformed
Prior art date
Application number
AT07855994T
Other languages
English (en)
Inventor
Josef Jirman
Richard Junek
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Application granted granted Critical
Publication of ATE533764T1 publication Critical patent/ATE533764T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
AT07855994T 2006-12-22 2007-12-21 Verfahren zur herstellung von solifenacin ATE533764T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060828A CZ300692B6 (cs) 2006-12-22 2006-12-22 Zpusob prípravy solifenacinu
PCT/CZ2007/000119 WO2008077357A2 (en) 2006-12-22 2007-12-21 A method for the preparation of solifenacin

Publications (1)

Publication Number Publication Date
ATE533764T1 true ATE533764T1 (de) 2011-12-15

Family

ID=39327062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07855994T ATE533764T1 (de) 2006-12-22 2007-12-21 Verfahren zur herstellung von solifenacin

Country Status (9)

Country Link
US (1) US20100145055A1 (de)
EP (1) EP2094693B1 (de)
AT (1) ATE533764T1 (de)
CZ (1) CZ300692B6 (de)
EA (1) EA015365B1 (de)
ES (1) ES2375668T3 (de)
PL (1) PL2094693T3 (de)
UA (1) UA96974C2 (de)
WO (1) WO2008077357A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2229387A1 (de) * 2007-12-04 2010-09-22 Cadila Healthcare Limited Verfahren zur herstellung einer chemisch und chiral reinen solifenacinbase und ihrer salze
SI3067353T1 (en) 2008-07-29 2018-03-30 Krka, D.D., Novo Mesto Process for the preparation of solifenacin salts and their inclusion in pharmaceutical dosage forms
US8765785B2 (en) 2010-07-05 2014-07-01 Crystal Pharma, S.A.U. Solifenacin salts
CN102887894A (zh) * 2011-07-18 2013-01-23 天津市医药集团技术发展有限公司 一种琥珀酸索利那新晶型及其制备方法
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
EP3753923A1 (de) 2019-06-19 2020-12-23 GH Research Limited Umkristallisierung von 5-methoxy-n,n-dimethyltryptamin (5-meo-dmt) in methyl tert.-butyl ether (mtbe) ohne zugabe eines antilösungsmittels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108992A (en) * 1976-03-10 1977-09-12 Meiji Seika Kaisha Ltd Purification of cefalexin
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
EP1714965A4 (de) * 2004-02-09 2007-12-19 Astellas Pharma Inc Solifenacinsuccinat enthaltende zusammensetzung
CA2560080A1 (en) * 2004-03-16 2005-09-22 Astellas Pharma Inc. Solifenacin-containing composition
JP3701964B1 (ja) * 2005-03-08 2005-10-05 アステラス製薬株式会社 キヌクリジン誘導体の新規な塩

Also Published As

Publication number Publication date
WO2008077357A3 (en) 2008-08-14
EP2094693B1 (de) 2011-11-16
CZ2006828A3 (cs) 2008-07-02
EA015365B1 (ru) 2011-06-30
EA200900744A1 (ru) 2009-12-30
WO2008077357A2 (en) 2008-07-03
ES2375668T3 (es) 2012-03-05
PL2094693T3 (pl) 2012-04-30
UA96974C2 (ru) 2011-12-26
EP2094693A2 (de) 2009-09-02
US20100145055A1 (en) 2010-06-10
CZ300692B6 (cs) 2009-07-15

Similar Documents

Publication Publication Date Title
EA200900744A1 (ru) Способ получения солифенацина
EP2412700A4 (de) Verfahren zur herstellung eines bizyklischen gamma-aminosäure-derivates
MY174776A (en) Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
NZ739757A (en) Processes for preparing jak inhibitors and related intermediate compounds
AR059916A1 (es) Procesos y productos intermedios para preparar compuestos esterico
ATE453622T1 (de) Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
BRPI0812625A2 (pt) processo para preparar um sal de cis-atracúrio
AR059296A1 (es) Compuesto de l-tartrato de s-zopiclona y proceso para resolver los enantiomeros de zopiclona.
ATE554086T1 (de) Scopin-salze und deren verwendung in verfahren zur herstellung von n-demethyl-tiotropium und tiotropiumbromid
EA200702161A1 (ru) Кристаллическая форма хинолинон-карбоксамидного соединения
KR970703342A (ko) 아자비시클릭 유도체의 제조 방법(Process for The Preparation of Azabicyclic Derivatives)
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE529408T1 (de) Verfahren zur herstellung eines vorläufers von montelukast
WO2009076602A8 (en) 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors
UA94614C2 (en) Process for the preparation of solifenacin
EA201170114A1 (ru) Способ получения бензоимидазол-2-илпиримидиновых производных
DE502006007443D1 (de) Verfahren zur herstellung von angereichertem isopulegol
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ZA201003718B (en) Stable crystalline salt of (r)-3-flurirphenyl-3,4,5-trifluorobenzylcaramic acid 1-azabicyclo [2.2.2] oct-3-yl ester
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
ATE514702T1 (de) Verfahren zur herstellung von clopidogrel und dabei verwendete zwischenprodukte
ATE523490T1 (de) Verfahren zur herstellung von pleuromutilinen
ATE533758T1 (de) Verfahren zur herstellung von enantiomerenreinem esomeprazol
ATE489367T1 (de) Verfahren und zwischenprodukt zur herstellung von donezepil
ATE538102T1 (de) Verfahren zur herstellung eines chinazolinderivats